Who are Perioperative magnesium sulfate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Magnesium Sulfate, Heptahydrate, Magnesium Sulfate low dose.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/perioperative-magnesium-sulfate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Perioperative magnesium sulfate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Perioperative magnesium sulfate (Perioperative magnesium sulfate) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte supplement / NMDA receptor antagonist. Area: Perioperative medicine / Anesthesia.

marketed Electrolyte supplement / NMDA receptor antagonist NMDA receptor, voltage-gated calcium channels Perioperative medicine / Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Perioperative magnesium sulfate (Perioperative magnesium sulfate) — Instituto Mexicano del Seguro Social. Magnesium sulfate acts as a natural calcium antagonist and NMDA receptor antagonist, reducing neuromuscular excitability and vascular smooth muscle contractility.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Perioperative magnesium sulfate TARGET	Perioperative magnesium sulfate	Instituto Mexicano del Seguro Social	marketed	Electrolyte supplement / NMDA receptor antagonist	NMDA receptor, voltage-gated calcium channels
Magnesium Sulfate, Heptahydrate	Magnesium Sulfate, Heptahydrate	University of Utah	marketed	Electrolyte supplement / anticonvulsant / bronchodilator	NMDA receptor, voltage-gated calcium channels
Magnesium Sulfate low dose	Magnesium Sulfate low dose	University of Monastir	phase 3	Electrolyte supplement / anticonvulsant	NMDA receptor, voltage-gated calcium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte supplement / NMDA receptor antagonist class)

Instituto Mexicano del Seguro Social · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Perioperative magnesium sulfate — Competitive Intelligence Brief. https://druglandscape.com/ci/perioperative-magnesium-sulfate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab